CAR-ITNK cells targeting CD70 and CLL1

· Tongji Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-ITNK cells targeting CD70 and CLL1, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Novel CAR-ITNK Cells Targeting CD70 and CLL1 for Refractory/Relapsed AML [EARLY_Phase 1]